1SOCIE G,SALOOJA N,COHEN A, et al. Nonmalignant late effects after allogeneic stem cell transplantation[J]. Blood,2003,101 (9) :3373-3385.
2POWLES R, MEHTA J, KULKARNI S, et al. Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomized trial [J].Lancet,2000,355 (9211) :1231-1237.
3de WIT D,van MECHELEN M ZANIN C, et al. Preferential activation of Th2 cells in chronic graft-versus-host reaction[J].J Immunol,1993,150 (2) :361-366.
4OKAMOTO I, KOHNO K, TANIMOTO T, et al. IL-18 prevents the development of chronic graft-versus-host disease in mice[J]. J Immunol,2000,164(11) :6067 -6074.
5WEINBERG K,BLAZAR BR,WAGNER J E, et al. Factors affecting thymic function after allogeneic stem cell transplantation[J]. Blood, 2001,97 (5) : 1458-1466.
6SHERER Y, SHOENFELD Y. Autoimmune diseases and autoimmunity post-bone marrow transplantation [J]. Bone Marrow Transplant, 1998,22(9) : 873-881.
7SATO N, KISHI K, YAGISAWA K, et al. Nephritic syndrome in a bone marrow transplant recipient with chronic graft-versus-host disease[J]. Bone Marrow Transplant, 1995,16 (2):303-305.
8BRUIJIN J A,van ELEVN E H, HOGENDOORN p C W, et al. Murine chronic graft-versus-host disease as a model for lupus nephritis[J]. Am J Pathol,1988,130(3):639-641.
9SHULMAN H M, SULLIVAN KM, WEIDEN P L, et al.Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients[J]. American Journal of Medicine,1980,69 (2). 204-217.
10AKPEK G,LEE S J,FLOWERS M E, et al. Performance of a new clinical grading system for chronic graft versus-host disease: a muhicenter study[J]. Blood, 2003,102(3) : 802-809.
4Bruijn JA, Van Elevn EH, Hogendoorn PCW,et al. Murine chronic graft-versus-host disease as a model for lupus nephritis[ J]. Am J Pathol, 1988,13 ( 3 ) :639 - 640.
